Suchergebnisse - "Widera, Marek"

PubPharm (11)

1

SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals

enthalten in: Nature communications | 2024

von Urschel, R. | Bronder, S. | Klemis, V. | +13

2

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2 : reactogenicity and immunogenicity in a prospective cohort study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Kohmer, N. | Stein, S. | Schenk, B. | +7

3

Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models

enthalten in: Nature communications | 2023

von Corleis, B. | Hoffmann, D. | Rauch, S. | +17

4

NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2022

von Hielscher, F. | Schmidt, T. | Klemis, V. | +9

5

Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics

enthalten in: Viruses | 2022

von Veleanu, A. | Kelch, M. | Ye, C. | +6

6

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

enthalten in: EBioMedicine | 2022

von Wilhelm, A. | Widera, M. | Grikscheit, K. | +12

7

Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults

enthalten in: Nature microbiology | 2022

von Romero-Olmedo, A. | Schulz, A. | Hochstätter, S. | +14

8

Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro

enthalten in: The Journal of infectious diseases | 2021

von Widera, M. | Wilhelm, A. | Hoehl, S. | +10

9

Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q

enthalten in: Viruses | 2021

von Wilhelm, A. | Toptan, T. | Pallas, C. | +6

10

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

enthalten in: Viruses | 2021

von Halwe, S. | Kupke, A. | Vanshylla, K. | +25